Historial de carrera de Ronald H. Abrahams
Antiguos cargos conocidos de Ronald H. Abrahams.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Winston Laboratories, Inc.
Winston Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Winston Laboratories, Inc. manufactures pharmaceutical products. It discovers, develops and commercializes therapeutics for pain. The company's proprietary technologies involve neuroactive compounds which affect the functioning of neurotransmitters. Winston Laboratories was founded by Joel E. Bernstein and is headquartered in Vernon Hills, IL. | Director de Operaciones | - | 16/01/2009 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1994 | 01/01/1994 |
ERGO SCIENCE CORPORATION | Presidente | - | - |
REATA PHARMACEUTICALS, INC. | Director de Operaciones | - | - |
Formación de Ronald H. Abrahams.
University of Illinois | Undergraduate Degree |
Loyola University of Chicago | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Chief Operating Officer | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Winston Laboratories, Inc.
Winston Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Winston Laboratories, Inc. manufactures pharmaceutical products. It discovers, develops and commercializes therapeutics for pain. The company's proprietary technologies involve neuroactive compounds which affect the functioning of neurotransmitters. Winston Laboratories was founded by Joel E. Bernstein and is headquartered in Vernon Hills, IL. | Health Technology |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Ergo Science Corp.
Ergo Science Corp. Publishing: Books/MagazinesConsumer Services Ergo Science Corp. engages in the provision of business information. It operates indirectly through its subsidiaries. The company was founded on January 23, 1990 and is headquartered in Birmingham, AL. | Consumer Services |
- Bolsa de valores
- Insiders
- Ronald H. Abrahams
- Experiencia